Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 611 of 1,261
  1. US 9750724

    Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases

    MEREO BIOPHARMA 2 LIMITED · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  2. US 9750705

    Agents useful for treating obesity, diabetes and related disorders

    The Regents of the University of California · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  3. US 9751878

    Tetrahydronaphthyridine somatostatin receptor 5 antagonists

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  4. US 9752143

    Locked nucleic acid inhibitor of miR-145 and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  5. US 9752152

    Organic compositions to treat beta-ENaC-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  6. US 9751921

    Apelin fusion proteins and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  7. US 9752144

    Inhibitors of MYH7B and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  8. US 9750708

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  9. US 9752118

    Method of directed differentiation producing corneal endothelial cells from neural crest stem cells by PDGFB and DKK2, compositions thereof, and uses thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  10. US 9751890

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  11. US 9751839

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  12. US 9744235

    Treatment of cardiovascular disorders with targeted nanoparticles

    The Board of Regents of the University of Oklahoma · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  13. US 9745376

    Anti-ανβ6 antibodies

    The Regents of the University of California · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  14. US 9745314

    MDM2 inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  15. US 9745255

    Meta-substituted biphenyl peripherally restricted FAAH inhibitors

    The Regents of the University of California · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  16. US 9744163

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  17. US 9744142

    Formulations of volatile anesthetics and methods of use for reducing inflammation

    The Board of Regents of the University of Texas System · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  18. US 9745266

    Indoline alkaloid compounds

    The Regents of the University of Colorado · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  19. US 9744137

    Topiramate compositions and methods of enhancing its bioavailability

    Supernus Pharmaceuticals, Inc. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  20. US 9745337

    Complex compounds of germanium, methods for producing same, and drugs

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU “WELDUP” · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  21. US 9745325

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  22. US 9744141

    Multifunctional nanoparticle designs and applications

    The Regents of the University of California · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  23. US 9745296

    Salts, co-crystals, and polymorphs of an anxiolytic compound

    IRONWOOD PHARMACEUTICALS, INC. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted
  24. US 9744214

    Methods and compositions for modulating myofibroblast activities

    The Regents of the University of California · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.